NCT05584228View on ClinicalTrials.gov

Medical Treatment Versus Surgery in Stricturing Small Bowel Crohn's Disease

NANot yet recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

October 1, 2027

Study Completion Date

October 1, 2027

Conditions
Crohn Disease
Interventions
DRUG

Azathioprine + infliximab

Combination therapy using 2-2.5 mg/kg oral azathioprine plus subcutaneous infliximab

PROCEDURE

Intestinal resection

Ileocolonic or small bowel resection

All Listed Sponsors
collaborator

Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives

OTHER

lead

Nantes University Hospital

OTHER

NCT05584228 - Medical Treatment Versus Surgery in Stricturing Small Bowel Crohn's Disease | Biotech Hunter | Biotech Hunter